NU SKIN ENTERPRISES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NU SKIN ENTERPRISES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,208	2,279	2,679	2,420	2,582	2,696	2,226	1,969	1,732	1,485
Cost of revenue	500	502	634	581	658	675	631	612	550	454
Gross profit	1,707	1,777	2,045	1,839	1,924	2,020	1,595	1,357	1,182	1,031
Research and development	24.3	22	23	30.1	23.3	27.2	23.3	22.6	13	10.8
General and administrative	554	565	662	616	636	654	556	547	479	432
Operating expenses	1,476	1,503	1,804	1,572	1,666	1,786	1,484	1,309	1,333	966
Operating income	231	274	241	267	258	234	111	48.3	-152	65.8
Interest expense	15.6	22.2	21.8	19.2	13.1	11	13.5	25.6	26.4	13.9
Other non-operating income	-18.3	-8.92	-21.2	-12.3	-1.33	-1.53	-8.38	3.87	2.94	-31.8
Pre-tax income	213	266	220	255	256	232	89	26.6	-175	196
Income tax	69.8	136	97.8	81.6	64.9	85.2	-15.8	18	-28.5	36
Net income	143	129	122	174	191	147	105	8.6	-147	160
EBITDA	304	346	324	344	332	310	183	119	-81.8	118
EPS, basic	2.58	2.45	2.21	3.13	3.66	2.93	2.10	0.17	-2.95	3.25
EPS, diluted	2.55	2.36	2.16	3.10	3.63	2.86	2.07	0.17	-2.95	3.18
Shares, basic (weighted)	55.4	52.8	55.2	55.5	52.3	50.2	50	49.7	49.7	49.3
Shares, diluted (weighted)	56.1	54.9	56.5	55.9	52.8	51.4	50.5	49.9	49.7	50.3

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	357	426	387	336	403	340	265	256	187	239
Short-term investments	10.9	11.8	11.3	8.41	21.2	15.2	13.8	11.8	11.1	1.21
Receivables				50.4	63.4	41.3	47.4	58.7	50.8	39.5
Inventory	250	253	296	276	314	400	346	280	190	179
Other current assets	13.3	14	15.8	16.4	14.7	17.6	18.4	17.8	13.7	13.1
Total current assets	714	778	799	740	903	873	760	702	539	548
Property, plant and equipment	445	465	465	454	468	454	445	433	380	377
Lease right-of-use assets			0	144	155	121	98.7	90.1	72.6	74
Goodwill	115	115	197	197	203	206	206	218	83.6	83.6
Intangible assets	63.6	67.6	90	80.3	89.5	77	66.7	95.3	74.3	42.6
Long-term investments					11.3	35.9	39.5	36.4	3.86	4.43
Other non-current assets	136	165	144	154	138	175	244	248	298	280
Total assets	1,474	1,590	1,694	1,769	1,957	1,906	1,821	1,809	1,469	1,405
Accounts payable	41.3	50.3	47.6	39	66.2	50	54	43.1	34.9	26.2
Accrued liabilities	275	319	323	290	447	372	280	254	218	218
Deferred revenue	13.5	14.9	13.8	12.5	18.2	22	18.7	12.6	7.8	7.2
Short-term debt	82.7	77.8	69.5	27.5	30	108	25	25	30	20
Total current liabilities	399	447	440	357	543	530	359	329	297	264
Long-term debt	334	311	361	334	305	269	377	478	364	204
Lease liabilities			0	106	112	88.8	76.5	70.9	58.4	57.6
Other non-current liabilities	76.8	127	112	96.8	102	106	110	107	97.5	74.5
Total liabilities	810	885	913	894	1,063	994	924	987	817	600
Total debt	417	389	430	362	335	376	402	503	394	224
Paid-in capital	440	466	553	558	580	602	613	622	628	636
Retained earnings	1,559	1,609	1,636	1,728	1,841	1,912	1,939	1,870	1,712	1,860
Treasury stock	-1,250	-1,305	-1,327	-1,325	-1,462	-1,527	-1,569	-1,570	-1,564	-1,575
Other comprehensive income	-84.1	-66.3	-79.9	-85.3	-64.8	-73.9	-86.5	-100	-125	-116
Shareholders' equity	664	705	782	875	894	913	897	822	651	805
Total equity	664	705	782	875	894	913	897	822	651	805
Total liabilities and equity	1,474	1,590	1,694	1,769	1,957	1,906	1,821	1,809	1,469	1,405

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	143	129	122	174	191	147	105	8.6	-147	160
Depreciation and amortization	72.4	71.6	83	76.7	74	76.3	72.5	70.9	69.8	52.3
Stock-based compensation	8.89	19.3	26.6	9.91	24.1	23.2	12.4	15.6	14.8	24.1
Deferred income tax	-0.18	44	-19.2	-0.29	-13.8	6.34	-51.4	-15.1	-55.5	0.02
Change in receivables	3.36	-0.1	-10.5	2.75	-11.2	20.2	-11.4	-22.7	-7.76	10.1
Change in inventory	9.8	7.54	-33.4	18.4	-31.1	-127	-2.97	-13.2	30.3	11.9
Change in payables	13.4	6.83	-9.16	-7.18	24.8	-13.3	9.26	-10.1	-7.29	-9.11
Cash from operations	275	303	203	178	379	142	108	119	112	80.3
Capital expenditures	-50.2	-60.2	-70.4	-66.1	-63.8	-68.6	-59.1	-58.5	-41.6	-34.3
Acquisitions	-8.69	-31.7	-38.5	-8.07	-14.9	-19	0	-77.3	0	0
Purchases of investments	-17.1	-11.3	-11.4	-8.43	-14.7	-16.2	-14	-16.9	-14.8	0
Sales and maturities of investments	18.1	11.3	11.5	11.2	14	15.1	5.93	18.1	18.4	10.2
Cash from investing	-57.9	-92	-109	-71.4	-79.4	-88.7	-67.1	-135	-38	171
Debt issued	234	67	582	145	115	155	460	110	15	55
Debt repaid	-56.2	-103	-553	-214	-143	-115	-433	-10	-125	-225
Stock issued	14.3	24.4	10.8
Share buybacks	-247	-71.7	-69.6	-0.83	-144	-80.4	-70	-13	0	-20
Dividends paid	-78.4	-76.1	-80.6	-82.2	-78.4	-76.3	-77	-77.6	-11.9	-11.8
Cash from financing	-135	-160	-117	-155	-245	-105	-99.5	10.7	-133	-202
Exchange rate effect					12.5	-11.2	-16.3	-3.54	-9.78	3.2
Net change in cash	67.9	69.2	-39.5	-51.3	67.1	-63.1	-74.9	-8.67	-69.2	51.7
Free cash flow	225	242	132	112	315	73	49	60.1	70.2	46
Interest paid	11.6	18.4	20.9	17.9	11.2	8.6	14.5	33.3	35.3	16.7
Income taxes paid	123	78.1	123	97.9	56.2	96	42.1	32.4	30.4	40.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.63 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	69.2%	Gross profit / revenue.
Operating margin	-0.8%	Operating income / revenue.
EBITDA margin	2.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.9%	Pre-tax income / revenue.
Net margin	-15.7%	Net income / revenue.
FCF margin	0.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.7%	Cash from operations / revenue.
Return on equity (ROE)	-39.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-19.3%	Net income / average total assets.
Return on invested capital (ROIC)	-1.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	3.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-14.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-12.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-10.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-12.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-13.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-11.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	-16.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-23.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	-13.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-18.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	15.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-3.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	15.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-2.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-28.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-9.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-26.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-34.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-2.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-32.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	23.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-3.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-2.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-4.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-8.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-6.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.98x	Current assets / current liabilities.
Quick ratio	0.94x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.75x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.39x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	19.1%	Total debt / total assets.
Liabilities / assets	51.6%	Total liabilities / total assets.
Net debt	$22.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.56x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-0.66x	Operating income / interest expense.
Working capital	$251.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	3.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$500.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.23x	Revenue / average total assets.
Fixed asset turnover	3.62x	Revenue / average property, plant and equipment.
Inventory turnover	2.21x	Cost of revenue / average inventory.
Days inventory	165 days	365 x average inventory / cost of revenue.
Receivables turnover	28.1x	Revenue / average receivables.
Days sales outstanding	13 days	365 x average receivables / revenue.
Days payables	32 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	145 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	78.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$4.45	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$28.30	Revenue / diluted weighted shares.
FCF per share	$0.22	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.05	Cash from operations / diluted weighted shares.
Book value per share	$11.17	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$10.29	Tangible book value / shares outstanding.
Cash per share	$3.94	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	108.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	185.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$225.4M	Share price x shares outstanding.
Enterprise value	$247.7M	Market cap + total debt - cash - short-term investments.
P/S	0.16x	Market cap / revenue.
P/B	0.42x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.45x	Market cap / tangible book value, when positive.
P/FCF	20.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	4.44x	Market cap / cash from operations, when positive.
EV/Sales	0.18x	Enterprise value / revenue.
EV/EBITDA	6.25x	Enterprise value / EBITDA, when both are positive.
EV/FCF	23.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.8%	Free cash flow / market cap.
Earnings yield	-96.0%	Net income / market cap (the inverse of P/E).
Dividend yield	5.2%	Dividends paid over the period / market cap.
Shareholder yield	14.1%	(Dividends paid + share buybacks) / market cap.

What was NU SKIN ENTERPRISES, INC.'s revenue in fiscal 2025?

NU SKIN ENTERPRISES, INC. reported revenue of $1.49B for fiscal 2025, 14.3% lower than the year before.

Was NU SKIN ENTERPRISES, INC. profitable in fiscal 2025?

Yes. Net income was $160.2M, a net margin of 10.8%.

How much free cash flow did NU SKIN ENTERPRISES, INC. generate in fiscal 2025?

Cash from operations of $80.3M minus capital expenditures of $34.3M left free cash flow of $46.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NU SKIN ENTERPRISES, INC.